Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-10-05 Sale |
2021-10-05 5:37 pm |
XERIS PHARMACEUTICALS INC | XERS | Schmid John P. Director |
5,659 | $0 | $0 | 0 (Direct) |
View |
| 2021-10-05 Sale |
2021-10-05 5:36 pm |
XERIS PHARMACEUTICALS INC | XERS | Edick Paul R Chief Executive Officer |
621,494 | $0 | $0 | 0 (Indirect Direct) |
View |
| 2021-10-05 Sale |
2021-10-05 5:36 pm |
XERIS PHARMACEUTICALS INC | XERS | Pieper Steven Chief Financial Officer |
158,108 | $0 | $0 | 0 (Direct) |
View |
| 2021-10-05 Sale |
2021-10-05 5:34 pm |
XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
494,780 | $0 | $0 | 0 (Direct) |
View |
| 2021-10-05 Sale |
2021-10-05 5:34 pm |
XERIS PHARMACEUTICALS INC | XERS | Hecht Beth See Remarks |
206,366 | $0 | $0 | 0 (Direct) |
View |
| 2021-10-05 Sale |
2021-10-05 5:33 pm |
XERIS PHARMACEUTICALS INC | XERS | JOHNSON KENNETH ERLAND See Remarks |
89,583 | $0 | $0 | 0 (Direct) |
View |
| 2021-10-05 Sale |
2021-10-05 5:32 pm |
XERIS PHARMACEUTICALS INC | XERS | Shannon John Patrick Jr See Remarks |
263,829 | $0 | $0 | 0 (Direct) |
View |
| 2021-04-12 Sale |
2021-04-13 5:06 pm |
XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
10,000 | $4.0725 | $40,725 | 496,824 (Direct) |
View |
| 2021-01-13 Sale |
2021-01-15 4:03 pm |
XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
10,000 | $6.0058 | $60,058 | 406,824 (Direct) |
View |
| 2021-01-11 Sale |
2021-01-12 4:02 pm |
XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
10,000 | $5.7244 | $57,244 | 416,824 (Direct) |
View |
| 2020-12-09 Purchase |
2020-12-10 4:52 pm |
XERIS PHARMACEUTICALS INC | XERS | Edick Paul R See Remarks |
10,000 | $4.0551 | $40,551 | 424,564 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-07-28 Option Award |
2021-07-29 6:06 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Pieper Steven See Remarks |
100,000 | $0 | 158,858 (Direct) |
View |
Ownership |
2021-07-29 6:04 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Pieper Steven See Remarks |
0 | $0 | 132,768 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-08 7:11 pm |
N/A 2031-06-08 |
XERIS PHARMACEUTICALS INC | XERS | PERSKY MARLA Director |
11,228 | $0 | 11,228 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-08 7:10 pm |
N/A 2031-06-08 |
XERIS PHARMACEUTICALS INC | XERS | SHERMAN JEFFREY W Director |
11,228 | $0 | 11,228 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-08 7:09 pm |
N/A 2031-06-08 |
XERIS PHARMACEUTICALS INC | XERS | HALKUFF DAWN Director |
11,228 | $0 | 11,228 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-08 7:08 pm |
N/A 2031-06-08 |
XERIS PHARMACEUTICALS INC | XERS | Schmid John P. Director |
11,228 | $0 | 11,228 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-08 7:08 pm |
N/A 2031-06-08 |
XERIS PHARMACEUTICALS INC | XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE Director |
11,228 | $0 | 11,228 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-01 4:22 pm |
N/A 2031-01-29 |
XERIS PHARMACEUTICALS INC | XERS | Edick Paul R See Remarks |
625,000 | $0 | 1,049,564 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-01 4:20 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Shannon John Patrick Jr See Remarks |
150,000 | $0 | 271,224 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-01 4:17 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
100,000 | $0 | 506,824 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-01 4:12 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | JOHNSON KENNETH ERLAND See Remarks |
65,000 | $0 | 91,890 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-01 4:11 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Hecht Beth See Remarks |
150,000 | $0 | 210,814 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-01 4:06 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Deutsch Barry M. See Remarks |
115,000 | $0 | 208,090 (Direct) |
View |
| 2020-12-16 Gift |
2020-12-17 4:40 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
10,000 | $0 | 426,824 (Direct) |
View |
| 2020-08-18 Option Award |
2020-08-20 6:01 pm |
N/A 2030-08-18 |
XERIS PHARMACEUTICALS INC | XERS | Shannon John Patrick Jr See Remarks |
100,000 | $0 | 221,224 (Direct) |
View |
| 2020-08-14 Option Award |
2020-08-17 4:35 pm |
N/A 2030-08-14 |
XERIS PHARMACEUTICALS INC | XERS | JOHNSON KENNETH ERLAND See Remarks |
100,000 | $0 | 126,890 (Direct) |
View |
| 2020-08-14 Option Award |
2020-08-17 4:26 pm |
N/A 2030-08-14 |
XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
25,000 | $0 | 461,824 (Direct) |
View |
| 2020-08-14 Option Award |
2020-08-17 4:25 pm |
N/A 2030-08-14 |
XERIS PHARMACEUTICALS INC | XERS | Hecht Beth See Remarks |
150,000 | $0 | 210,814 (Direct) |
View |
| 2020-08-14 Option Award |
2020-08-17 3:45 pm |
N/A 2030-08-14 |
XERIS PHARMACEUTICALS INC | XERS | Deutsch Barry M. See Remarks |
100,000 | $0 | 193,090 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-15 4:54 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Hecht Beth See Remarks |
3,731 | $2.26 | 60,814 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-15 4:53 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Shannon John Patrick Jr See Remarks |
3,731 | $2.26 | 121,224 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-15 4:53 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Deutsch Barry M. See Remarks |
3,731 | $2.26 | 93,090 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-15 4:52 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | JOHNSON KENNETH ERLAND See Remarks |
775 | $2.26 | 26,890 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-04 9:06 pm |
N/A 2030-06-04 |
XERIS PHARMACEUTICALS INC | XERS | SHERMAN JEFFREY W Director |
11,228 | $0 | 11,228 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-04 9:04 pm |
N/A 2030-06-04 |
XERIS PHARMACEUTICALS INC | XERS | PERSKY MARLA Director |
11,228 | $0 | 11,228 (Direct) |
View |